Century Therapeutics
Vision
Century Therapeutics is working towards a world in which patients are no longer limited by first-generation cell therapies. The company wants to change cancer therapy for everyone by harnessing the power of adult stem cells to develop curative therapies.
Approach
Century’s genetically-engineered immune effector cell therapies are specifically designed to target hematologic and solid cancers and overcome barriers in autologous cell therapies.
Century (IPSC) went public in June 2021.